rs6679677
A SNP in the RSBN1 gene on chromosome 1. Its most notable genotype is A;A: 5.2x risk for T1D; 3.3x for RA
- Gene
- RSBN1
- Location
- Chr 1113,761,186 (GRCh38)
- Highest magnitude
- 3.0Important
- Tested on
- 23andMe, AncestryDNA
- Minor allele frequency
- 4%
Genotypes
As shown in 23andMe and AncestryDNA files.
- A;AMost notableBad5.2x risk for T1D; 3.3x for RA
- A;CBad1.8x risk for T1D; 2x risk for RA
- C;CGoodnormal
On SNPedia: (A;A), (A;C), (C;C). Magnitude rates how notable a genotype is from 0 to 10, not how risky it is.
Frequency
Share of each genotype in 9 HapMap populations.
- AverageA;A <1% A;C 5% C;C 95%
- European ancestry (Utah)A;A <1% A;C 21% C;C 78%
- Han Chinese (Beijing)A;A 0% A;C 0% C;C 100%
- Japanese (Tokyo)A;A 0% A;C 0% C;C 100%
- Yoruba (Nigeria)A;A 0% A;C 0% C;C 100%
- African ancestry (Southwest US)A;A 0% A;C 4% C;C 97%
- Gujarati IndianA;A 0% A;C 1% C;C 99%
- Mexican ancestry (Los Angeles)A;A 2% A;C 5% C;C 93%
- Maasai (Kenya)A;A 0% A;C <1% C;C 99%
- TuscanA;A 0% A;C 12% C;C 88%
Related
Conditions, medicines and genes
Notes
From SNPedia
Show notes, about 400 words
rs6679677 has been reported in a large study to be associated with rheumatoid arthritis. The risk allele (oriented to the dbSNP entry) is (A); the odds ratio associated with heterozygotes is 1.98 (CI 1.72-2.27), and for homozygotes, 3.32 (CI 1.93-5.69). rs6679677 was also reported in the same study to be associated with type-1 diabetes. The risk allele (oriented to the dbSNP entry) is (A); the odds ratio associated with heterozygotes is 1.82 (CI 1.59-2.09), and for homozygotes, 5.19 (CI 3.15-8.55). Recently (Feb 2008), it has been asserted that the association between rs6679677 and type-1 diabetes is actually completely due to a closely linked, potentially causal variant identified as rs2476601, which is also known as Arg620Trp. In this study, apparently the largest to date, the odds ratio for the risk allele (of rs6679677) was reported to be 1.88 (CI: 1.66-2.13). DeCode reports that the CC genotype is associated with 1.05x higher odds of Crohn's disease. Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment. Genome-wide association studies: progress and potential for drug discovery and development. Worldwide population differentiation at disease-associated SNPs. Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes. Type 1 diabetes in the BB rat: a polygenic disease. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Correcting "winner's curse" in odds ratios from genomewide association findings for major complex human diseases. Pathway analysis of GWAS provides new insights into genetic susceptibility to 3 inflammatory diseases. Representation of genetic association via attributable familial relative risks in order to identify polymorphisms functionally relevant to rheumatoid arthritis. Allelic variants in the PHTF1-PTPN22, C12orf30 and CD226 regions as candidate susceptibility factors for the type 1 diabetes in the Estonian population. The susceptibility loci juvenile idiopathic arthritis shares with other autoimmune diseases extend to PTPN2, COG6, and ANGPT1. Novel association strategy with copy number variation for identifying new risk Loci of human diseases.
A;A
5.2x risk for type-1 diabetes 3.3x risk for rheumatoid arthritis
A;C
1.8x risk for type-1 diabetes 2x risk for rheumatoid arthritis
Source and license
Adapted from rs6679677 on SNPedia, using a snapshot taken October 16, 2026. SNPedia content is shared under CC BY-NC-SA 3.0 US, and this page is shared under the same license.
SNPedia is a community-edited wiki. Its entries can be incomplete, out of date or wrong, and nothing here is a diagnosis or medical advice. Magnitude is a community rating of how interesting a genotype is, not a risk score.